Therapeutic Impact of Nanoparticle Therapy Targeting Tumor-Associated Macrophages.

about

Immunology, Immunotherapy, and Translating Basic Science into the Clinic for Bladder Cancer Targeting the Microenvironment in High Grade Serous Ovarian Cancer

P2860

Q58705140-1A867FA2-4AA9-4F68-9FE1-1207145A0FA3 Q58789499-09241FF3-97EB-406D-8E21-B078027CBA33

P2860

Therapeutic Impact of Nanoparticle Therapy Targeting Tumor-Associated Macrophages.

Item

http://www.wikidata.org/entity/Q50042447

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Therapeutic Impact of Nanoparticle Therapy Targeting Tumor-Associated Macrophages.

@en

Therapeutic Impact of Nanoparticle Therapy Targeting Tumor-Associated Macrophages.

@nl

type

Item

label

Therapeutic Impact of Nanoparticle Therapy Targeting Tumor-Associated Macrophages.

@en

Therapeutic Impact of Nanoparticle Therapy Targeting Tumor-Associated Macrophages.

@nl

prefLabel

Therapeutic Impact of Nanoparticle Therapy Targeting Tumor-Associated Macrophages.

@en

Therapeutic Impact of Nanoparticle Therapy Targeting Tumor-Associated Macrophages.

@nl

P1476

Therapeutic Impact of Nanoparticle Therapy Targeting Tumor-Associated Macrophages.

@en

P2093

Alex Cole

http://www.w3.org/2001/XMLSchema#string

Courtney A Penn

http://www.w3.org/2001/XMLSchema#string

Dongli Yang

http://www.w3.org/2001/XMLSchema#string

Hong Zong

http://www.w3.org/2001/XMLSchema#string

Jae-Young Lim

http://www.w3.org/2001/XMLSchema#string

James Baker

http://www.w3.org/2001/XMLSchema#string

Kun Yang

http://www.w3.org/2001/XMLSchema#string

Ronald J Buckanovich

http://www.w3.org/2001/XMLSchema#string

Sascha N Goonewardena

http://www.w3.org/2001/XMLSchema#string

P2860

Microenvironmental regulation of metastasis

The role of myeloid cells in the promotion of tumour angiogenesis

Macrophage diversity enhances tumor progression and metastasis

Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor

Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial.

A folate receptor beta-specific human monoclonal antibody recognizes activated macrophage of rheumatoid patients and mediates antibody-dependent cell-mediated cytotoxicity.

VEGFR3 inhibition chemosensitizes ovarian cancer stemlike cells through down-regulation of BRCA1 and BRCA2.

A phase 3 trial of bevacizumab in ovarian cancer.

CX3CR1 delineates temporally and functionally distinct subsets of myeloid-derived suppressor cells in a mouse model of ovarian cancer

Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial.

P304

96-106

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1535-7163.MCT-17-0688

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29133618

http://www.w3.org/2001/XMLSchema#string

P921

nanoparticle

P932

5752569

http://www.w3.org/2001/XMLSchema#string

Therapeutic Impact of Nanoparticle Therapy Targeting Tumor-Associated Macrophages.

about

P2860

P2860

Therapeutic Impact of Nanoparticle Therapy Targeting Tumor-Associated Macrophages.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932